精神分裂症康复技术的示范推广应用

注册号:

Registration number:

ChiCTR2100043537 

最近更新日期:

Date of Last Refreshed on:

2021-06-14 00:58:26 

注册时间:

Date of Registration:

2021-02-21 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

精神分裂症康复技术的示范推广应用

Public title:

Demonstration, popularization and application of rehabilitation techniques for schizophrenia

注册题目简写:

English Acronym:

研究课题的正式科学名称:

精神分裂症康复技术的示范推广应用

Scientific title:

Demonstration, popularization and application of rehabilitation techniques for schizophrenia

研究课题代号(代码):

Study subject ID:

Z191100008319009

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

廉思源 

研究负责人:

任艳萍 

Applicant:

Liansiyuan 

Study leader:

Renyanping 

申请注册联系人电话:

Applicant telephone:

+86 15910959060

研究负责人电话:

Study leader's
telephone:

+86 13520079201

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1405307095@qq.com

研究负责人电子邮件:

Study leader's E-mail:

1405307095@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市西城区德胜门外安康胡同5号

研究负责人通讯地址:

北京市西城区德胜门外安康胡同5号

Applicant address:

Beijing Anding Hospital affiliated to Capital Medical University, No. 5 Ankang Hutong, Deshengmen, Xicheng District, Beijing

Study leader's address:

5 Ankang Hutong, Deshengmen, Xicheng District, Beijing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

首都医科大学附属北京安定医院

Applicant's institution:

Beijing Anding Hospital affiliated to Capital Medical University

研究负责人所在单位:

首都医科大学附属北京安定医院

Affiliation of the Leader:

Beijing Anding Hospital affiliated to Capital Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

(2020)科研第(45)号-202053FS-2

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

首都医科大学附属北京安定医院伦理委员会

Name of the ethic committee:

Ethics Committee of Beijing Anding Hospital affiliated to Capital Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2020-07-13 00:00:00

伦理委员会联系人:

贾津京

Contact Name of the ethic committee:

Jia Jinjing

伦理委员会联系地址:

北京市西城区德胜门外安康胡同5号首都医科大学附属北京安定医院伦理委员会办公室

Contact Address of the ethic committee:

Beijing Anding Hospital affiliated to Capital Medical University, No. 5 Ankang Hutong, Deshengmen, Xicheng District, Beijing

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 10-58340320

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

首都医科大学附属北京安定医院

Primary sponsor:

Beijing Anding Hospital affiliated to Capital Medical University

研究实施负责(组长)单位地址:

北京市西城区德胜门外安康胡同5号首都医科大学附属北京安定医院

Primary sponsor's address:

Beijing Anding Hospital affiliated to Capital Medical University, No. 5 Ankang Hutong, Deshengmen, Xicheng District, Beijing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京市

市(区县):

西城区

Country:

China

Province:

Beijing

City:

Xicheng District

单位(医院):

首都医科大学附属北京安定医院

具体地址:

首都医科大学附属北京安定医院

Institution
hospital:

Beijing Anding Hospital affiliated to Capital Medical University

Address:

Beijing Anding Hospital affiliated to Capital Medical University, No. 5 Ankang Hutong, Deshengmen, Xicheng District, Beijing

经费或物资来源:

北京市科委资助

Source(s) of funding:

Funded by Beijing Municipal Science and Technology Commission

研究疾病:

精神分裂症  

Target disease:

Schizophrenia

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

单臂 

Study design:

Single arm 

研究目的:

在前期北京市推广应用的基础上扩大推广范围,将精神分裂症康复技术推广应用到全国基层精神卫生机构,采取集中的理论培训和带教,现场实地指导的推广模式,完成对精防医生的培训,让更多的精神分裂症患者受益。  

Objectives of Study:

On the basis of the previous promotion in Beijing, the scope of promotion should be expanded, the rehabilitation techniques for schizophrenia should be extended to grass-roots mental health institutions across the country, and the promotion mode of centralized theoretical training and teaching and on-the-spot guidance should be adopted. complete the training of fine prevention doctors to benefit more patients with schizophrenia.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1 共病其它精神疾病:精神发育迟滞、痴呆及严重认知功能障碍者;
2 精神活性物质依赖者;
3 合并有严重的脑、肝、肺、肾或造血系统等躯体疾病者。

Exclusion criteria:

1. Comorbid other mental diseases: mental retardation, dementia and severe cognitive impairment.
2. Patients who are dependent on psychoactive substances.
3. Patients with severe somatic diseases such as brain, liver, lung, kidney or trophoblast system.

研究实施时间:

Study execute time:

From 2019-03-01 00:00:00 To 2021-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-03-01 00:00:00 To 2021-12-31 00:00:00

干预措施:

Interventions:

组别:

研究组

样本量:

400

Group:

Research group

Sample size:

干预措施:

康复训练

干预措施代码:

Intervention:

Rehabilitation training

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

北京西城区平安医院 

单位级别:

二级甲等 

Institution
hospital:

Ping'an Hospital, Xicheng District, Beijing

Level of the institution:

Secondary B

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

北京市东城区精神卫生保健院 

单位级别:

一级甲等 

Institution
hospital:

Beijing Dongcheng Mental Health Care Center

Level of the institution:

Primary A

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

北京海淀精神卫生防治院 

单位级别:

二级甲等 

Institution
hospital:

Beijing Haidian Mental Health Prevention and Treatment Hospital

Level of the institution:

Secondary A

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

北京市昌平区精神卫生保健院 

单位级别:

二级合格 

Institution
hospital:

Mental Health Care Hospital of Changping District, Beijing

Level of the institution:

Secondary

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

北京市通州区精神病院 

单位级别:

二级甲等 

Institution
hospital:

Beijing Tongzhou District Psychiatric Hospital

Level of the institution:

Secondary

国家:

中国

省(直辖市):

河北省 

市(区县):

 

Country:

China

Province:

Hebei

City:

单位(医院):

河北省第六医院 

单位级别:

三级甲等 

Institution
hospital:

The sixth Hospital of Hebei Province

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

山东 

市(区县):

 

Country:

China

Province:

Shandong

City:

单位(医院):

济宁市精神病防治院 

单位级别:

三级甲等 

Institution
hospital:

Jining Psychiatric Prevention and treatment Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

湖北 

市(区县):

 

Country:

China

Province:

Hubei

City:

单位(医院):

武汉大学人民医院 

单位级别:

三级甲等 

Institution
hospital:

People's Hospital of Wuhan University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

湖北 

市(区县):

 

Country:

China

Province:

Hubei

City:

单位(医院):

湖北省孝感市社会福利和医疗康复中心 

单位级别:

三级甲等 

Institution
hospital:

Hubei Xiaogan Social Welfare and Medical Rehabilitation Center

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

湖北 

市(区县):

 

Country:

China

Province:

Hubei

City:

单位(医院):

湖北省荆州市公安县人民医院 

单位级别:

三级甲等 

Institution
hospital:

People's Hospital of Gongan County, Jingzhou City, Hubei Province

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

吉林 

市(区县):

 

Country:

China

Province:

Jilin

City:

单位(医院):

吉林省神经精神病院 

单位级别:

三级甲等 

Institution
hospital:

Jilin Provincial Neuropsychiatric Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

吉林 

市(区县):

 

Country:

China

Province:

Jilin p

City:

单位(医院):

吉林省神经精神病院 

单位级别:

三级甲等 

Institution
hospital:

Jilin Provincial Neuropsychiatric Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

四川 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

四川省自贡市第五人民医院 

单位级别:

三级甲等 

Institution
hospital:

The Fifth people's Hospital of Zigong City, Sichuan Province

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

福建 

市(区县):

 

Country:

China

Province:

Fujian

City:

单位(医院):

福建省三明市台江医院 

单位级别:

三级甲等 

Institution
hospital:

Taijiang Hospital, Sanming City, Fujian Province

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

黑龙江 

市(区县):

 

Country:

China

Province:

Heilongjiang

City:

单位(医院):

大庆市第三医院 

单位级别:

三级甲等 

Institution
hospital:

Daqing Third Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

甘肃 

市(区县):

 

Country:

China

Province:

Gansu

City:

单位(医院):

甘肃省天水市第三人民医院 

单位级别:

二级甲等 

Institution
hospital:

The Third People's Hospital of Tianshui City, Gansu Province

Level of the institution:

Secondary A

国家:

中国

省(直辖市):

江苏 

市(区县):

 

Country:

China

Province:

Jiangsu

City:

单位(医院):

江苏省淮安市第三人民医院 

单位级别:

三级甲等 

Institution
hospital:

The Third People's Hospital of Huaian City, Jiangsu Province

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

新疆维吾尔自治区 

市(区县):

 

Country:

China

Province:

Xinjiang Uygur Autonomous region

City:

单位(医院):

石河子精神病院 

单位级别:

三级甲等 

Institution
hospital:

Shihezi Psychiatric Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

内蒙古自治区 

市(区县):

 

Country:

China

Province:

Inner Mongolia Autonomous region

City:

单位(医院):

内蒙古自治区第三医院 

单位级别:

三级甲等 

Institution
hospital:

The third Hospital of Inner Mongolia Autonomous region

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

云南 

市(区县):

 

Country:

China

Province:

Yunnan

City:

单位(医院):

云南省精神病院 

单位级别:

三级甲等 

Institution
hospital:

Yunnan Provincial Psychiatric Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

安徽 

市(区县):

 

Country:

China

Province:

Anhui

City:

单位(医院):

安徽合肥市精神病院 

单位级别:

三级甲等 

Institution
hospital:

Anhui Hefei Psychiatric Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

临床症状

指标类型:

主要指标

Outcome:

Clinical symptoms

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

生活质量

指标类型:

主要指标

Outcome:

Quality of life

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

社会功能

指标类型:

主要指标

Outcome:

Social function

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 55 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

未使用

Randomization Procedure (please state who generates the random number sequence and by what method):

Not used

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

N/A

Blinding:

N/A

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

https://edcweb.smindu.com/

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

https://edcweb.smindu.com/

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

基于互联网的EDC

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

electronic data capture

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2021-02-21 08:34:14